Spinal cord demyelination combined with hyperhomocysteinemia: a case report

Neuropsychiatr Dis Treat. 2014 Nov 3:10:2057-9. doi: 10.2147/NDT.S70963. eCollection 2014.

Abstract

Hyperhomocysteinemia (HHcy) has been recognized as an independent risk factor for atherosclerotic vascular disease. Here we report a patient who suffered from spinal cord demyelination combined with HHcy. The patient was admitted to our hospital with a diagnosis of acute myelitis. However, hormone therapy was ineffective. Further investigations revealed that he had HHcy and a homozygous mutation of the gene encoding methylenetetrahydrofolate reductase (MTHFR) c.677C>T, which is a key enzyme involved in homocysteine metabolism. In view of these findings, we treated the patient with B vitamins and his symptoms gradually improved. Spinal magnetic resonance imaging performed 3 months after onset showed near recovery of the lesion. To our knowledge, similar reports are rare.

Keywords: demyelination; homocysteine; hyperhomocysteinemia; methylation; methylenetetrahydrofolate reductase.

Publication types

  • Case Reports